Author: Krajewski, Rafał; Gołębiowska, Justyna; Makuch, Sebastian; Mazur, Grzegorz; Agrawal, Siddarth
Title: Update on Serologic Testing in COVID–19 Cord-id: pbc8nmkg Document date: 2020_9_15
ID: pbc8nmkg
Snippet: • The role of serological testing is crucial in the clinical management of COVID-19. • In this paper, we discuss the utility of anti–SARS–CoV–2 serology testing in a clinical setting. • Utilizing qualitative and quantitative anti–SARS–CoV2 IgM and IgG detection in the advanced stage of the infection is recommended.
Document: • The role of serological testing is crucial in the clinical management of COVID-19. • In this paper, we discuss the utility of anti–SARS–CoV–2 serology testing in a clinical setting. • Utilizing qualitative and quantitative anti–SARS–CoV2 IgM and IgG detection in the advanced stage of the infection is recommended.
Search related documents:
Co phrase search for related documents- absence presence and acute ali lung injury: 1, 2, 3
- absence presence and acute phase: 1, 2, 3, 4, 5, 6, 7, 8
- absence presence and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- absence presence and additional test: 1
- absence presence and low number: 1, 2, 3
- absence presence and low respiratory: 1
- absence presence and low sensitivity: 1, 2, 3, 4, 5, 6, 7
- absence presence and lung injury: 1, 2, 3, 4
- absence presence and lymphocyte neutrophil: 1, 2, 3, 4, 5
- absence presence and lymphocyte neutrophil ratio: 1
- accumulate evidence and acute respiratory: 1
- accumulate evidence and lymphocyte neutrophil: 1, 2
- accumulate evidence and lymphocyte neutrophil ratio: 1, 2
- active disease and acute phase: 1, 2, 3, 4, 5
- active disease and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69
- active disease and low number: 1, 2, 3
- active disease and low sensitivity: 1
- active disease and lung injury: 1, 2, 3, 4
- active disease and lymphocyte neutrophil ratio: 1, 2
Co phrase search for related documents, hyperlinks ordered by date